Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Acron extended its options to repurchase VKK shares

11/28/23 AKRN

Acron reported for 9 months of 2023 by IFRS

11/28/23 AKRN

Blocked 69% of SPB Exchange clients' money

11/28/23 SPBE

RusHydro reported for 9 months of 2023 by IFRS

11/28/23 HYDR

TMK reported for 9 months of 2023 by RAS

11/28/23 TRMK

Positive Technologies' client base grows 21% faster in 2023

11/28/23 POSI

Gazprom prepares to launch new production facilities

11/28/23 GAZP

Yandex will create advertising for business with the help of neural networks

11/28/23 YNDX

European Commission approves proposal to ban the sale of diamonds from Russia

11/28/23 ALRS

Rosseti Center and Volga Region reported for 9 months of 2023 by IFRS

11/28/23 MRKP